Harvard Bioscience
HBIO
HBIO
84 hedge funds and large institutions have $129M invested in Harvard Bioscience in 2015 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $54K
Holders
84
Holding in Top 10
1
Calls
–
Puts
$54K
Top Buyers
| 1 | +$4.42M | |
| 2 | +$3.05M | |
| 3 | +$2.62M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.46M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.13M |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$1.57M | |
| 3 | -$538K | |
| 4 |
FA
Friess Associates
Greenville,
Delaware
|
-$524K |
| 5 |
PSC
Piper Sandler & Co
Minneapolis,
Minnesota
|
-$437K |